- Report
- May 2024
- 187 Pages
Global
From €4444EUR$4,500USD£3,698GBP
- Report
- May 2024
- 187 Pages
Global
From €4444EUR$4,500USD£3,698GBP
- Report
- April 2024
- 183 Pages
Global
From €4444EUR$4,500USD£3,698GBP
- Report
- April 2024
- 183 Pages
Global
From €4444EUR$4,500USD£3,698GBP
- Report
- February 2024
- 179 Pages
Global
From €4444EUR$4,500USD£3,698GBP
- Report
- February 2024
- 184 Pages
Global
From €4444EUR$4,500USD£3,698GBP
- Report
- January 2024
- 188 Pages
Global
From €4444EUR$4,500USD£3,698GBP
- Report
- July 2024
- 100 Pages
Global
From €2593EUR$2,625USD£2,157GBP
€3704EUR$3,750USD£3,082GBP
- Report
- July 2024
- 150 Pages
Global
From €2593EUR$2,625USD£2,157GBP
€3704EUR$3,750USD£3,082GBP
- Report
- June 2024
- 200 Pages
Global
From €5496EUR$5,565USD£4,573GBP
€7852EUR$7,950USD£6,533GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1383EUR$1,400USD£1,150GBP
€1975EUR$2,000USD£1,643GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €864EUR$875USD£719GBP
€1235EUR$1,250USD£1,027GBP
- Drug Pipelines
- January 2024
- 60 Pages
Global
From €1037EUR$1,050USD£863GBP
€1481EUR$1,500USD£1,233GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €864EUR$875USD£719GBP
€1235EUR$1,250USD£1,027GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €864EUR$875USD£719GBP
€1235EUR$1,250USD£1,027GBP
- Report
- October 2024
- 144 Pages
Global
From €2469EUR$2,500USD£2,054GBP
- Report
- September 2024
- 129 Pages
Global
From €2469EUR$2,500USD£2,054GBP
- Report
- August 2024
- 168 Pages
Global
From €2469EUR$2,500USD£2,054GBP
- Report
- June 2024
- 141 Pages
Global
From €2469EUR$2,500USD£2,054GBP
- Report
- June 2024
- 144 Pages
Global
From €2469EUR$2,500USD£2,054GBP
The Infectious Diseases Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat infectious diseases. These drugs are used to treat a wide range of illnesses, from common colds to more serious conditions such as HIV/AIDS, malaria, and tuberculosis. The market is highly competitive, with many companies vying for a share of the market.
Infectious Diseases Drugs are typically developed through a combination of research and development, clinical trials, and regulatory approval. Companies in the market must also ensure that their products are safe and effective for use in humans.
Some of the major players in the Infectious Diseases Drugs market include Pfizer, GlaxoSmithKline, Merck, Sanofi, and Johnson & Johnson. These companies are involved in the development and production of a wide range of drugs used to treat infectious diseases. Show Less Read more